samedan logo
 
 
spacer
home > pmps > autumn 2008 > labelling: clarity and compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Labelling: Clarity and Compliance

The legislation surrounding the clear and accurate labelling of pharmaceuticals, and the inclusion, where appropriate, of accompanying instruction leaflets, is becoming increasingly stringent. As a consequence, in addition to having to include mandatory information on medicinal products, pharmaceutical manufacturers and packaging companies are now required to ensure that this information is legible, easy to understand, and indelible. In order to achieve this using conventional printing technology, considerable time, money and resources can be required, leading these companies to look for a simpler and more cost-effective alternative.

Thankfully, a new generation of easy to operate and cost-effective printing equipment has been developed in response to these requirements, enabling the standards to be met with minimal expenditure and stress. Furthermore, these latest printers provide a sustainable solution, able to cater for evolving regulations and standards in order that they can continue to meet user requirements in the long term.

STRINGENT REGULATIONS

OEMs and packaging companies must now comply with the European Parliament Directive 2001/83/EC, which provides a number of guidelines concerning labelling pharmaceuticals and providing supporting documentation...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mark Beauchamp is European Marketing Manager for Citizen Systems Europe. With over 18 years’ experience at the company and a wealth of technical knowledge, he is adept at helping channel partners and endusers alike to understand the latest printing technology. Beginning his career in the marketing team, Mark then moved into technical support where he provided distributor support across the European network. In addition to working with Citizen’s clients across Europe, the Middle East and Africa, he is actively involved in product development. Mark is Chairman of AIM UK, the British chapter of the Auto-ID manufacturers’ association.
spacer
Mark Beauchamp
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioNet and Sartorius’ company BIA Separations collaborate on production process development of mRNA vaccines

Ajdovšcina, Slovenia & Bangkok, Thailand, 02 November 2021: BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, today announced the successful development of an optimized mRNA manufacturing process.
More info >>

White Papers

Keeping Abreast of the Competitive Environment in Clinical Development

Thomson Reuters

Strategic management of a therapy area requires hard decisions to be made about which programs to invest in and which to let go. Understanding the rapidly changing competitive environment for your drug candidates is a key input into these decisions. It is easy to lose track of the broader picture when a clinical program is in progress and get blindsided by external events.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement